135 related articles for article (PubMed ID: 38687213)
1. Antipsychotic Use and Risk of Breast Cancer in Women With Severe Mental Illness: Replication of a Nationwide Nested Case-Control Database Study.
Solmi M; Lähteenvuo M; Tanskanen A; Corbeil O; Mittendorfer-Rutz E; Correll CU; Tiihonen J; Taipale H
Schizophr Bull; 2024 Apr; ():. PubMed ID: 38687213
[TBL] [Abstract][Full Text] [Related]
2. Antipsychotic Use and Risk of Low-Energy Fractures in People With Schizophrenia: A Nationwide Nested Case-Control Study in Finland.
Solmi M; Lähteenvuo M; Correll CU; Tanskanen A; Tiihonen J; Taipale H
Schizophr Bull; 2023 Jan; 49(1):78-89. PubMed ID: 36334051
[TBL] [Abstract][Full Text] [Related]
3. Antipsychotic use and risk of breast cancer in women with schizophrenia: a nationwide nested case-control study in Finland.
Taipale H; Solmi M; Lähteenvuo M; Tanskanen A; Correll CU; Tiihonen J
Lancet Psychiatry; 2021 Oct; 8(10):883-891. PubMed ID: 34474013
[TBL] [Abstract][Full Text] [Related]
4. Prolactin-Elevating Antipsychotics and the Risk of Endometrial Cancer.
Klil-Drori AJ; Yin H; Abenhaim HA; du Fort GG; Azoulay L
J Clin Psychiatry; 2017 Jun; 78(6):714-719. PubMed ID: 28199787
[TBL] [Abstract][Full Text] [Related]
5. Understanding the Limitations of the Odds Ratio in a Case-Control Study of the Association Between Breast Cancer and Exposure to Antipsychotic Drugs.
Andrade C
J Clin Psychiatry; 2021 Nov; 82(6):. PubMed ID: 34813689
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer risks following antipsychotic use in women with bipolar disorder versus schizophrenia: A territory-wide nested case-control study spanning two decades.
Chu RYK; Wei Y; Osborn DP; Ng VWS; Cheng FWT; Chan SKW; Chan SSM; Wong ICK; Chan EWY; Lai FTT
Psychiatry Res; 2023 Aug; 326():115287. PubMed ID: 37320990
[TBL] [Abstract][Full Text] [Related]
7. Use of antipsychotics and risk of breast cancer: a Danish nationwide case-control study.
Pottegård A; Lash TL; Cronin-Fenton D; Ahern TP; Damkier P
Br J Clin Pharmacol; 2018 Sep; 84(9):2152-2161. PubMed ID: 29858518
[TBL] [Abstract][Full Text] [Related]
8. Association between long-term use of prolactin-elevating antipsychotics in women and the risk of breast cancer: What are the clinical implications?
Hope JD; Keks NA; Copolov DL
Australas Psychiatry; 2023 Apr; 31(2):205-208. PubMed ID: 36927059
[TBL] [Abstract][Full Text] [Related]
9. Risk of Breast Cancer With Prolactin Elevating Antipsychotic Drugs: An Observational Study of US Women (Ages 18-64 Years).
Rahman T; Sahrmann JM; Olsen MA; Nickel KB; Miller JP; Ma C; Grucza RA
J Clin Psychopharmacol; 2022 Jan-Feb 01; 42(1):7-16. PubMed ID: 34864772
[TBL] [Abstract][Full Text] [Related]
10. Risk of malignancy in patients with schizophrenia or bipolar disorder: nested case-control study.
Hippisley-Cox J; Vinogradova Y; Coupland C; Parker C
Arch Gen Psychiatry; 2007 Dec; 64(12):1368-76. PubMed ID: 18056544
[TBL] [Abstract][Full Text] [Related]
11. [Antipsychotic-drug-induced hyperprolactinemia: physiopathology, clinical features and guidance].
Besnard I; Auclair V; Callery G; Gabriel-Bordenave C; Roberge C
Encephale; 2014 Feb; 40(1):86-94. PubMed ID: 23928066
[TBL] [Abstract][Full Text] [Related]
12. Prolactin response to antipsychotics: An inpatient study.
Dehelean L; Romosan AM; Papava I; Bredicean CA; Dumitrascu V; Ursoniu S; Romosan RS
PLoS One; 2020; 15(2):e0228648. PubMed ID: 32017792
[TBL] [Abstract][Full Text] [Related]
13. Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management.
Haddad PM; Wieck A
Drugs; 2004; 64(20):2291-314. PubMed ID: 15456328
[TBL] [Abstract][Full Text] [Related]
14. Risk of breast cancer in risperidone users: A nationwide cohort study.
Reutfors J; Wingård L; Brandt L; Wang Y; Qiu H; Kieler H; Bahmanyar S
Schizophr Res; 2017 Apr; 182():98-103. PubMed ID: 27823949
[TBL] [Abstract][Full Text] [Related]
15. Long-term treatment with clozapine and other antipsychotic drugs and the risk of haematological malignancies in people with schizophrenia: a nationwide case-control and cohort study in Finland.
Tiihonen J; Tanskanen A; Bell JS; Dawson JL; Kataja V; Taipale H
Lancet Psychiatry; 2022 May; 9(5):353-362. PubMed ID: 35334224
[TBL] [Abstract][Full Text] [Related]
16. Risk Factors, Incidence, and Outcomes of Neuroleptic Malignant Syndrome on Long-Acting Injectable vs Oral Antipsychotics in a Nationwide Schizophrenia Cohort.
Guinart D; Taipale H; Rubio JM; Tanskanen A; Correll CU; Tiihonen J; Kane JM
Schizophr Bull; 2021 Oct; 47(6):1621-1630. PubMed ID: 34013325
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of Antipsychotic Use for Reducing Risk of Work Disability: Results From a Within-Subject Analysis of a Swedish National Cohort of 21,551 Patients With First-Episode Nonaffective Psychosis.
Solmi M; Taipale H; Holm M; Tanskanen A; Mittendorfer-Rutz E; Correll CU; Tiihonen J
Am J Psychiatry; 2022 Dec; 179(12):938-946. PubMed ID: 36200276
[TBL] [Abstract][Full Text] [Related]
18. [Prolactin, antipsychotics and breast cancer: is there a connection?].
Sabbe T; Detraux J; De Hert M
Tijdschr Psychiatr; 2016; 58(9):641-9. PubMed ID: 27639886
[TBL] [Abstract][Full Text] [Related]
19. Antipsychotic medication, prolactin elevation, and ovarian function in women with schizophrenia and schizoaffective disorder.
Canuso CM; Goldstein JM; Wojcik J; Dawson R; Brandman D; Klibanski A; Schildkraut JJ; Green AI
Psychiatry Res; 2002 Aug; 111(1):11-20. PubMed ID: 12140115
[TBL] [Abstract][Full Text] [Related]
20. Association between antipsychotic drug use and cataracts in patients with bipolar disorder: A population-based, nested case-control study.
Chu CS; Chou PH; Chen YH; Huang MW; Hsu MY; Lan TH; Lin CH
J Affect Disord; 2017 Feb; 209():86-92. PubMed ID: 27889598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
